NOCD delivers virtual-first, evidence-based OCD care through licensed therapists offering face-to-face video ERP sessions combined with self-help tools and personalized peer communities. Since launching in 2018, the company has expanded to all 50 states and internationally and now operates a network of 300+ OCD-specialized therapists. NOCD delivers more than 250,000 therapy sessions annually and reports an average 35% reduction in OCD symptom severity among members. The company conducted an 18-month retrospective study of over 3,500 therapy members—the largest OCD treatment study reported by the firm—to codify the efficacy of its care model. NOCD also reports coverage for more than 130 million commercial lives and emphasizes analytics and outcomes capabilities for payers. Going forward, NOCD plans to use new funding to expand its therapist network, enhance analytics and outcomes offerings for payers, and run public-awareness efforts with partners such as Howie Mandel to redefine perception of OCD. NOCD operates a telehealth platform focused exclusively on OCD treatment and has established the “Community‑Driven Therapy” category. Its core product pairs a nationwide network of licensed, ERP‑specialty therapists with always‑on peer groups, self‑help tools, and face‑to‑face telehealth sessions. The company delivers more than 12,000 live telehealth visits per month and reports outcomes showing a 40% improvement in patient health within as few as 90 days, after over 18 consecutive months of rapid growth. NOCD has partnered with leading health insurers so that more than a third of Americans have access to NOCD therapy as a covered benefit. The company is broadening clinical training to cover Hoarding Disorder, body‑focused repetitive behaviors (BFRBs), and common comorbid anxiety and mood disorders. NOCD is launching virtual partial hospitalization (PHP), intensive outpatient (IOP), and psychiatric treatment services and is expanding internationally to reach patients earlier and offer more long‑term services. NOCD operates an online therapy app focused on identifying and treating obsessive-compulsive disorder. The company says COVID-19 was a catalyst for product growth and an increase in therapy sessions. NOCD announced a $12 million Series A round to scale its operations. The funding will be used primarily to expand its provider network to all 50 states to reach the more than 8 million people in the U.S. with OCD. The company also plans to invest in technology and data science to ensure effective, convenient OCD therapy regardless of patient location. Investors in the round include Health Enterprise Partners, Hyde Park Angels, and previous backers 7Wire Ventures and Chicago Ventures. NOCD is a Chicago-based digital behavioral health company that identifies and manages people with obsessive-compulsive disorder (OCD). Led by CEO and founder Stephen Smith, NOCD operates a provider network designed to bring effective treatment to people with OCD. Via its app, members receive video-based diagnostic assessments and therapy with a specially trained clinician. The company raised $4M in a Series A financing to support growth. The round was led by Chicago Ventures with participation from 7Wire Ventures, Meridian Street Capital and Hyde Park Angels. NOCD intends to use the funds for nationwide expansion of its provider network. nOCD provides a treatment application for individuals with obsessive-compulsive disorder that collects 54 metrics to help researchers and clinicians use data to improve OCD treatment and connect with patients. The app helps users find mental health treatment and access clinical trials, and it analyzes anonymized data to understand the efficacy and adherence rates of interventions. It also enables distribution of interventions to patients more easily. Led by founder and CEO Stephen Smith, the Chicago, IL-based company raised $1M in funding. The company intends to use the funds to expand globally.

Total raised

$84M

Funding rounds

5

Latest round

Equity

Latest activity

Jan 2023